AU
UK
CA
US
IND
NZ
CRISPR Therapeutics AG -Collaboration brings together complementary capabilities to co-develop and co-commercialize SRSD107, a next generation, long-acting Factor XI (FXI)small interfering RNA (siRNA) for the treatment of thromboembolic disorders- -SRSD107 demonstrated peak reductions in FXI activity >93% and increases in activated partial thromboplastin time …
Eva Marie Uzcategui / Bloomberg via Getty Images Key Takeaways The parent companies of TJ Maxx and Ross Dress for Less are slated to share first-quarter results this week, offering investors clues about how tariffs are impacting discount retailers. Import taxes may increase this …
Hospitality industry software provider Agilysys (NASDAQ:AGYS) reported Q1 CY2025 results exceeding the market’s revenue expectations , with sales up 19.4% year on year to $74.27 million. On the other hand, the company’s full-year revenue guidance of $310 million at the midpoint came in 2.8% …
LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025. Mr. …
CAMDEN, N.J., May 19, 2025--(BUSINESS WIRE)--American Water Works Company, Inc. (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., announced today that it has agreed with Nexus Regulated Utilities, LLC, a subsidiary of Nexus Water Group, Inc. ("Nexus Water Group"), …
Fourth quarter service revenue of $172 million and total revenue of $177 million Fiscal year 2025 service revenue of $693 million and total revenue of $715 million 2025 Cash flow from operations of $64 million CAMPBELL, Calif., May 19, 2025--(BUSINESS WIRE)--8x8, Inc. (NASDAQ: EGHT), …
Annual Revenue Includes Recurring Revenue of $170.1M and Subscription Revenue Growth of 39.5% Annual Record Adjusted EBITDA of $53.8M and Free Cash Flow of $52.3M Annual Revenue Expected To Grow To $308M to $312M In Fiscal 2026 With Full Year Adjusted EBITDA of 20% …
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient Populations Poster Presentations on New Pivotal Phase 3 Analyses UnderscoreTanruprubart’s Rapid and Sustained Treatment Effect and …
AUSTIN, Texas, May 19, 2025 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands, retailers, manufacturers and distributors, today announced that Chief Financial Officer Daniel Lentz will present and host …
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President, and Interim …
Please wait processing your request...